Stock Price Forecast

April 25, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AMEDISYS INC chart...

About the Company

Amedisys, Inc. is an American healthcare company based in Baton Rouge, Louisiana. They are one of the largest home health providers and second largest hospice care provider in the United States. Amedisys provides in-home skilled nursing, physical therapy, occupational therapy and speech language pathology, medical social work, home aides, and hospice and bereavement services, with 11 million patient care visits in 2011. Amedisys employs more than 21,000 individuals at more than 500 locations in 39 states and Washington, D.C. In 2010, annual revenues were approximately $1.6 billion. Amedisys was ranked 999 on the Fortune 1000 in 2011. In June 2023, Optum agreed to acquire Amedisys for $3.3 billion.

Exchange

Nasdaq

$2B

Total Revenue

8K

Employees

$3B

Market Capitalization

-396.07

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AMED News

AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024

on MSN ago, source:

AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the first quarter ...

Amedisys: Q1 Earnings Snapshot

1d ago, source:

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter net income of $14.4 million. On a per-share basis, the Baton Rouge, Louisiana-based company ...

Analysts Offer Insights on Healthcare Companies: Amedisys (AMED) and Gilead Sciences (GILD)

1d ago, source:

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amedisys (AMED – Research Report) and Gilead Sciences (GILD ...

Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates

1d ago, source: Zacks.com on MSN

Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Amedisys (AMED) is a Strong Value Stock

3d ago, source:

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes

2d ago, source:

Dividend Aristocrats are stocks on the S&P 500 that have consistently raised their payouts for 25 years or more. Studies show ...

Long-Term Care Market Projected to Reach USD 2168.1 Billion by 2032 | Market.us

1d ago, source: PharmiWeb

Term Care Market size is expected to be worth around USD 2,168.1 Billion by 2032 from USD 1,180.0 Billion in 2023, growing at ...

DOJ case against UnitedHealth could take years to resolve, says BoA

on MSN ago, source:

BofA Securities said an antitrust case brought by the US Department of Justice against UnitedHealth Group (UNH) would likely ...

Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings

4d ago, source: Citizen Tribune

Shares are broadly higher in Europe and Asia as investors focus on the latest flurry of corporate earnings. The upbeat start ...

New Research Suggests That Cutting Exposure to Common Chemicals Could Slow Aging

12d ago, source:

Researchers at Nagoya University in Japan have discovered that aldehydes are metabolic byproducts associated with premature ...

Here's What Key Metrics Tell Us About Encompass Health (EHC) Q1 Earnings

1d ago, source: Zacks.com on MSN

Encompass Health (EHC) reported $1.32 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 13.4%. EPS of $1.12 for the same period compares to $0.88 a year ...

The Latest | Trump's legal team again asks appeals court to intervene in hush money case

6d ago, source: Citizen Tribune

A full jury of 12 people and six alternates has been seated Donald Trump’s hush money case, setting the stage for expected ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...